In addition, the study gives insight into the correlation between FKBPL expression and ERα as a known effector of endometrial proliferation, and VEGF-A as one of the central pro-angiogenic factors and target proteins for anti-angiogenic therapy in EEC patients. Here, ESR1 is linked to exstrophy-epispadias complex.